Renal, bladder and prostate cancer : an update : the proceedings of the V Congress on Progress and Controversies in Oncological Urology (PACIOU V), held in Rotterdam, the Netherlands, October 1998 /

Saved in:
Bibliographic Details
Meeting name:Congress on Progress and Controversies in Oncological Urology (5th : 1998 : Rotterdam, Netherlands)
Imprint:New York : Parthenon Pub., c1999.
Description:xi, 290 p. : ill. ; 27 cm.
Language:English
Subject:
Format: Print Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/3855925
Hidden Bibliographic Details
Other authors / contributors:Kurth, Karl H.
Mickisch, G.
Schröder, F. H.
ISBN:1850700818
Notes:Includes bibliographical references and index.

MARC

LEADER 00000nam a22000004a 4500
001 3855925
003 ICU
005 20030528022900.0
008 990205s1999 nyua b 001 0 eng c
010 |a  99019720  
020 |a 1850700818 
035 |a 99019720 
040 |a DNLM/DLC  |c DLC  |d DLC  |d NhCcYBP  |d OrLoB-B  |d OCoLC 
042 |a pcc 
050 4 |a RC280.U74  |b C66 1998 
060 4 |a WJ 358  |b C749 1999 
082 0 0 |a 616.99/46  |2 21 
111 2 |a Congress on Progress and Controversies in Oncological Urology  |n (5th :  |d 1998 :  |c Rotterdam, Netherlands) 
245 0 0 |a Renal, bladder and prostate cancer :  |b an update : the proceedings of the V Congress on Progress and Controversies in Oncological Urology (PACIOU V), held in Rotterdam, the Netherlands, October 1998 /  |c edited by Karl H. Kurth, Gerald H. Mickisch & Fritz H. Schröder. 
260 |a New York :  |b Parthenon Pub.,  |c c1999. 
300 |a xi, 290 p. :  |b ill. ;  |c 27 cm. 
336 |a text  |b txt  |2 rdacontent  |0 http://id.loc.gov/vocabulary/contentTypes/txt 
337 |a unmediated  |b n  |2 rdamedia  |0 http://id.loc.gov/vocabulary/mediaTypes/n 
338 |a volume  |b nc  |2 rdacarrier  |0 http://id.loc.gov/vocabulary/carriers/nc 
504 |a Includes bibliographical references and index. 
505 0 0 |g Sect. 1.  |t Renal cell carcinoma.  |g 1.  |t Molecular genetics of renal cell carcinoma /  |r E. Enquist, M. M. Walther and W. M. Linehan.  |g 2.  |t Limits of cure by surgery in renal cell carcinoma /  |r Z. Kirkali.  |g 3.  |t Organ-sparing surgery: magic bullet or tragic insanity? /  |r H. P. Van Poppel and L. V. Baert.  |g 4.  |t Transabdominal or retroperitoneal approach for tumor nephrectomy: an easy choice? /  |r D. Jacqmin.  |g 5.  |t Surgery for metastatic renal cell carcinoma: a matter of attitude? /  |r G. H. Mickisch.  |g 6.  |t Interferons in metastatic renal cell carcinoma: a tradition to be maintained? /  |r S. D. Fossa.  |g 7.  |t Interleukin-2 in renal cell carcinoma /  |r J. Atzpodien, J. Buer and S. Sel /  |r [et al.].  |g 8.  |t Gene therapeutic approaches for renal cell carcinoma: has the future arrived? /  |r J. W. Simons.  |g 9.  |t Cytotoxic T lymphocyte priming versus tolerance induction /  |r C. J. M. Melief, S. Schoenberger and R. J. Toes /  |r [et al.] --  |g Sect. 2.  |t Prostate cancer, localized disease.  |g 10.  |t Prostate cancer in Japan: what are the differences? /  |r K. Okada, Y. Suzuki and H. Tsuka /  |r [et al.].  |g 11.  |t Decreasing prostate cancer mortality in the USA. Is the value of screening already proven? /  |r P. C. Albertsen.  |g 12.  |t Update on the European Randomized Study of Screening for Prostate Cancer: light at the end of the tunnel /  |r L. J. Denis.  |g 13.  |t What is the optimal strategy for early detection of prostate cancer? /  |r J. Hugosson.  |g 14.  |t How many biopsies should be taken for proper diagnosis and grading? /  |r R. F. Hoedemaeker, A. E. Boeken Kruger and T. H. Van der Kwast.  |g 15.  |t Accuracy of grading: can it be replaced by other prognostic tissue factors? Present and future /  |r T. H. Van der Kwast and A. B. Houtsmuller.  |g 16.  |t Is cure of prostate cancer possible in those for whom it is necessary? /  |r P. T. Scardino, T. M. Wheeler and M. W. Kattan.  |g 17.  |t Can aggressive treatment be avoided in those who may not need it? /  |r M. Menon and A. Tewari.  |g 18.  |t Advances in radiotherapy of localized prostate cancer: improved effectiveness? /  |r M. K. Gospodarowicz, P. Warde and C. Catton /  |r [et al.].  |g 19.  |t Minimal invasive treatment alternatives for localized prostate cancer using thermal therapy or cryosurgery /  |r B. Djavan, C. Seitz and M. Marberger --  |g Sect. 3.  |t Prostate cancer, advanced disease.  |g 20.  |t Endocrine treatment of prostate cancer: the future after maximum androgen blockade and the role of PSA monitoring /  |r F. H. Schroder.  |g 21.  |t Antiandrogen monotherapy /  |r P. Iversen.  |g 22.  |t Quality of life in prostate cancer: preliminary results of two studies in patients with extensive disease /  |r G. van Andel and K. H. Kurth.  |g 23.  |t Intermittent endocrine therapy for prostate cancer /  |r N. Bruchovsky, L. H. Klotz and J. M. Crook /  |r [et al.].  |g 24.  |t New approaches to drug development in prostate cancer /  |r M. A. Eisenberger --  |g Sect. 4.  |t Bladder cancer.  |g 25.  |t Can intravesical chemotherapy prevent progression of superficial bladder cancer? /  |r F. M. J. Debruyne and J. A. Witjes.  |g 26.  |t Is intravesical BCG superior to chemotherapy? /  |r A. P. M. van der Meijden.  |g 27.  |t How long should adjuvant BCG be given? /  |r D. L. Lamm.  |g 28.  |t Urinary cytokines after intravesical immunotherapy: are they predictors? /  |r T. M. de Reijke, E. C. de Boer and K. H. Kurth /  |r [et al.].  |g 29.  |t Is bladder preservation possible in transitional carcinoma of T[subscript 1]G[subscript 3]? /  |r A. Brauers and G. Jakse.  |g 30.  |t Orthotopic urinary diversion in transitional cell carcinoma: are there limits? /  |r U. E. Studer and R. D. Mills.  |g 31.  |t The place for systemic treatment in invasive bladder carcinoma /  |r K. H. Kurth.  |g 32.  |t Gene therapy in metastatic transitional cell carcinoma of the bladder /  |r G. H. Mickisch.  |g 33.  |t Contemporary approaches for chemotherapy of metastatic urothelial cancer /  |r D. Raghavan. 
650 0 |a Kidneys  |x Cancer  |v Congresses.  |0 http://id.loc.gov/authorities/subjects/sh2010009509 
650 0 |a Bladder  |x Cancer  |v Congresses.  |0 http://id.loc.gov/authorities/subjects/sh2010008266 
650 0 |a Prostate  |x Cancer  |v Congresses.  |0 http://id.loc.gov/authorities/subjects/sh2010010103 
650 1 2 |a Kidney Neoplasms  |v congresses. 
650 2 2 |a Urinary Bladder Neoplasms. 
650 2 2 |a Prostatic Neoplasms. 
650 7 |a Bladder  |x Cancer.  |2 fast  |0 http://id.worldcat.org/fast/fst00834067 
650 7 |a Kidneys  |x Cancer.  |2 fast  |0 http://id.worldcat.org/fast/fst00987386 
650 7 |a Prostate  |x Cancer.  |2 fast  |0 http://id.worldcat.org/fast/fst01079479 
700 1 |a Kurth, Karl H.  |0 http://id.loc.gov/authorities/names/n84026195  |1 http://viaf.org/viaf/30930033 
700 1 |a Mickisch, G. 
700 1 |a Schröder, F. H.  |0 http://id.loc.gov/authorities/names/n87812787  |1 http://viaf.org/viaf/250350047 
901 |a ToCBNA 
903 |a HeVa 
035 |a (OCoLC)151984537 
929 |a cat 
999 f f |i 3899bb4d-3a6e-5abf-8734-e5ffa1a71b7c  |s 1dba3b7b-1130-5ccb-baee-e28860edb3dd 
928 |t Library of Congress classification  |a RC280.U74 C66 1998  |l ASR  |c ASR-SciASR  |i 6296464 
927 |t Library of Congress classification  |a RC280.U74 C66 1998  |l ASR  |c ASR-SciASR  |e BELF  |e CRERAR  |b 50772148  |i 6302197